Tag Archives: health insurance

Co-Pay Offset Programs and the New Health Insurance Marketplace: Will the Feds Say No?

By Mark McAndrew. As the health insurance marketplaces begin enrollment this week and go live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers, payers and the millions of consumers purchasing health insurance for the first time through an exchange.  Many of these issues, such as the cost […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , , , , , , , | Leave a comment

Co-Pay Offset Programs and Health Insurance Marketplaces: Causes for Concern

Co-Pay Offset Programs and Health Insurance Marketplaces As the health insurance marketplaces begin enrollment next week and go-live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers, payers and millions of consumers who will be purchasing health insurance for the first time through an exchange.  Many of these […]
Posted in Guest Blog, healthcare, Op-Ed | Also tagged , , , , , , , | Leave a comment

Messaging in Healthcare: Making Sound and Fury Signify Something

by Les Funtleyder Recently, there was a bit of a dust-up over whether it was appropriate for the Secretary of Health and Human Services (HHS) to engage the National Football League (NFL) to help HHS with the process of drumming-up enrollment for health insurance exchanges. In the end, the NFL and other sports leagues decided […]
Posted in Market Access, Patient Communication, patient education, Strategy | Also tagged , , , , , , | 1 Comment

Those Amazing 'Gold Plated, Cadillac Care' Drug Programs

by Tom Norton Not too many years ago, while employed by one of America’s leading Rx manufacturers, I remember stepping up to a retail drug store counter to pick up a prescription.  As the pharmacist handed me my script, he said, “Wow.  I don’t know what kind of health insurance you have, but I have […]
Posted in FDA, Global, Guest Blog, healthcare, Legal, Market Access, pricing, Regulatory, Strategy | Also tagged , , , , , , , , , , , , , , , , , | Leave a comment

FT Healthcare Conference: Society as Stakeholder

Speakers at the 2nd annual Financial Times US Healthcare and Life Sciences conference in New York last week discussed the cost of health, and the implications of an increasingly vocal and influential stakeholder group: the local populace. After opening remarks from Andrew Jack, FT’s prolific pharmaceuticals correspondent, Pfizer CEO Ian Read took the stage at […]
Posted in Europe, Events, Global, healthcare, leadership, Market Access, Orphan Drugs, People, pricing, R&D, Regulatory, Strategy, Technology | Also tagged , , , , , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta